KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aramark (ARMK) Asset Writedowns and Impairment (2020 - 2026)

Historic Asset Writedowns and Impairment for Aramark (ARMK) over the last 5 years, with Q1 2026 value amounting to $6.1 million.

  • Aramark's Asset Writedowns and Impairment changed N/A to $6.1 million in Q1 2026 from the same period last year, while for Jan 2026 it was $24.2 million, marking a year-over-year increase of 3331.13%. This contributed to the annual value of $8.9 million for FY2025, which is 5080.83% down from last year.
  • Aramark's Asset Writedowns and Impairment amounted to $6.1 million in Q1 2026.
  • In the past 5 years, Aramark's Asset Writedowns and Impairment registered a high of $18.3 million during Q4 2022, and its lowest value of $2.1 million during Q3 2023.
  • Its 4-year average for Asset Writedowns and Impairment is $10.8 million, with a median of $9.5 million in 2023.
  • Data for Aramark's Asset Writedowns and Impairment shows a peak YoY increase of 77264.88% (in 2024) and a maximum YoY decrease of 77264.88% (in 2024) over the last 5 years.
  • Aramark's Asset Writedowns and Impairment (Quarter) stood at $18.3 million in 2022, then tumbled by 88.62% to $2.1 million in 2023, then surged by 772.65% to $18.2 million in 2024, then crashed by 66.69% to $6.1 million in 2026.
  • Its last three reported values are $6.1 million in Q1 2026, $18.2 million for Q3 2024, and $2.1 million during Q3 2023.